This topic contains a solution. Click here to go to the answer

Author Question: Why will a woman have a higher BAC than a man if other factors are equal? a. Women tend to have ... (Read 56 times)

crobinson2013

  • Hero Member
  • *****
  • Posts: 535
Why will a woman have a higher BAC than a man if other factors are equal?
 
  a. Women tend to have more body fat, which affects absorption.
  b. Women have more blood to dilute the alcohol in their system.
  c. Women have more muscle than men, affecting absorption.
  d. Women react to carbonation differently than men.

Question 2

Why must managers review hours worked by salaried employees?
 
  a. To ensure length of service is accurate
  b. To ensure use of hourly workers is minimized
  c. To ensure correct work categories are reflected
  d. To ensure taxes and contributions are deducted



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

wfdfwc23

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

A

Answer to Question 2

C




crobinson2013

  • Member
  • Posts: 535
Reply 2 on: Aug 2, 2018
:D TYSM


cam1229

  • Member
  • Posts: 329
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

The newest statin drug, rosuvastatin, has been called a superstatin because it appears to reduce LDL cholesterol to a greater degree than the other approved statin drugs.

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

The most destructive flu epidemic of all times in recorded history occurred in 1918, with approximately 20 million deaths worldwide.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library